Introduction
============

According to the WHO/FAO definition, probiotics are "live micro-organisms which, when ingested in adequate amounts, confer a health benefit on the host" ([@B15]). During the last years, many lactic acid bacteria (LAB) have been studied for their probiotic potential, exploiting the Generally recognized as safe (GRAS) and Qualified presumption of safety (QPS) status possessed by some species. Many LAB are part of the normal microbiota of diverse districts of the human body and several others play fundamental roles in the production of fermented foods and for this reason are ingested in considerable amounts by consumers. Although *Bifidobacterium*, *Enterococcus*, *Lactococcus*, and *Pediococcus* genera include probiotic strains, most probiotic bacteria on the market today belong to the genus *Lactobacillus*. Unfortunately, most probiotics strains generally do not possess good technological characteristics and must therefore be added to fermented foods together with the technological strains. Although a number of probiotic strains are commercially available worldwide, the identification and characterization of new strains from different species is desirable as confirmed by many studies in this field published in recent years ([@B27]; [@B45]; [@B14]; [@B42]).

As a member of LAB, *Streptococcus thermophilus* is identified as a thermophilic group of bacteria and it is used as starter in a great number of dairy products, thus being considered the second most important species of industrial LAB after *Lactococcus lactis*. It was estimated that over 10^21^ live bacteria are consumed annually by the human population as live cells, thus leading this species to achieve a market value of approximately 40 billion US\$ ([@B25]).

The technological use of *S. thermophilus* is mainly related to its capability to rapidly acidify the substrate, a particularly important feature, since it is known that a pH decrease induces modifications in bacterial ([@B36]) and also yeast ([@B7], [@B8]) population composition. This is particularly relevant for aspects related to food safety, since most pathogenic bacteria grow very slowly or not at all at acidic pH. *S. thermophilus* is also well-known for production of folate, which is a necessary component of the human diet ([@B54]). Different LAB have been checked for their ability to produce folate and some fermented dairy products were reported to contain good amounts of this molecules, e.g., up to 110 μg of folate per liter in yogurt, due to the activity of LAB ([@B48]). Of the two species present in yogurt, *Lactobacillus delbrueckii* subsp. *bulgaricus* and *S. thermophilus*, only the latter is known to product folate. It has been reported that consume of food containing folate-producing bacteria is able to increase plasma folate concentration in humans ([@B48]). In addition, particular attention has been given to the role of probiotics in the reduction of invasion in cancer cells studies ([@B28]). Beneficial effects of LAB in cancer therapy are not related only to their immunomodulatory effects. They have been indicated the expression of different genes involved in cell transformation, migration and invasion and it has to be noted that the anti-cancer properties of probiotics bacteria could be strains dependent ([@B41]). Therefore, investigation of cytotoxic activity against different cancer cells could be very interesting feature of newly isolated bacteria.

The aim of this study was to select new potential probiotic *S. thermophilus* strains among a group of eight strains isolated in Italy from different dairy environments, which already had shown good technological properties. In particular, the genome of these eight strains had been sequenced and analyzed for the presence of genes related to bacteriocins and production of exopolysaccharides ([@B65]). Moreover, acidification kinetics ([@B65]), growth at different temperatures ([@B57]) and at different pH values ([@B56]), along with the growth dynamics using different energy sources ([@B58]) were evaluated previously. Our work examined the existence of *S. thermophilus* strains with both good probiotic and technological properties. Since this species has enormous relevance as technological starter, the opportunity to take a good advantage from strains of this this multipurpose species for the food industry and human health contemporarily appears of great interest. Hence, we studied the capability to withstand the transit through the gastrointestinal tract and the ability to hydrolyze bile salts. The absence of hemolytic activity and of transmissible antibiotic resistance was also examined, along with the capability to produce biogenic amines such as histamine and tyramine. Finally, we looked for health-related traits, namely the production of extracellular folic acid (vitamin B9) and the ability to attach and inhibit the growth of human HT-29 colorectal adenocarcinoma cells.

Materials and Methods {#s1}
=====================

Bacterial Strains and Standard Growth Conditions
------------------------------------------------

The strains of *S*. *thermophilus* used in this work are listed in **Table [1](#T1){ref-type="table"}**. *Lactobacillus rhamnosus* GG (ATCC 53103) was included in most tests as reference strain for probiotic properties. Streptococci were routinely grown at 37°C in M17 medium (Difco, United States) containing 0.5% lactose, unless otherwise stated. All bacteria were stored at -80°C in M17 containing 20% (v/v) glycerol. Each strain was sub-cultured three times in M17 broth prior to its use.

###### 

Strains of *S. thermophilus* used in this study.

  Strain       Geographical region     Isolation matrix     Animal    Reference
  ------------ ----------------------- -------------------- --------- -----------
  1F8CT        Veneto                  Curd from raw milk   Cow       [@B61]
  MTH17CL396   Valle d'Aosta           Fontina cheese       Cow       [@B62]
  M17PTZA496   Valle d'Aosta           Fontina cheese       Cow       [@B62]
  TH982        Campania                Mozzarella curd      Buffalo   [@B61]
  TH985        Campania                Mozzarella whey      Buffalo   [@B61]
  TH1435       Friuli Venezia Giulia   Raw milk             Goat      [@B63]
  TH1436       Friuli Venezia Giulia   Raw milk             Goat      [@B63]
  TH1477       Veneto                  Raw milk             Cow       [@B60]
                                                                      

Antibiotic Susceptibility Test
------------------------------

Antibiotic susceptibility tests were performed by using the agar overlay diffusion method, according to the National Committee for Clinical Laboratory Standards ([@B66]). Fourteen antibiotics, commonly recommended by the European Food Safety authority ([@B17]) were used, namely amoxicillin (10 μg), ampicillin (10 μg), cephalexin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), cloxacillin (5 μg), erythromycin (15 μg), gentamicin (10 μg), kanamycin (30 μg), penicillin G (10 IU), streptomycin (10 μg), tetracycline (30 μg), trimethoprim (5 μg), and vancomycin (30 μg). All strains were cultured from the stock two times prior to assay in 10 ml of M17 broth, then they were incubated at 37°C for 24 h. Plates containing 16 ml of M17 medium were overlaid with 4 ml of M17 soft agar inoculated with 200 μl of overnight cultures to give a final concentration of about 10^7^ cells/ml in the overlay. After solidification, antibiotic disks (Liofilchem, Italy) were placed on the surface and plates were incubated at 37°C for 24 h. Finally, inhibition halo diameters were measured and compared to the values proposed by [@B10] to score strains as resistant, intermediate or susceptible. The test was performed in triplicate. *Escherichia coli* ATCC 25922 was used as quality control of the antibiotic disks.

Hemolytic Activity Test
-----------------------

Fresh cultures of *S. thermophilus* strains were streaked on M17 plates containing 5% (w/v) of sheep blood (Thermo Fisher Scientific, United States), incubated at 37°C for 48 h and then checked for the presence of hemolytic haloes. *Staphylococcus aureus* ATCC 6538 and *Lb. rhamnosus* GG were included as positive and negative control, respectively ([@B47]). The experiment was repeated three times with three technical replicates each.

Resistance to Simulated Gastrointestinal Conditions
---------------------------------------------------

The resistance of *S*. *thermophilus* strains to conditions simulating those of the gastro-intestinal tract was tested as previously described ([@B19]) with the following modifications. The basic juice for the gastrointestinal assay contained (per liter) calcium chloride, 0.11 g; potassium chloride, 1.12 g; sodium chloride, 2.0 g; potassium dihydrogen phosphate, 0.4 g. It was sterilized by autoclaving at 121°C for 15 min. The artificial gastric juice, prepared 1 h prior to use, contained (per liter) 3.5 g swine mucin (Sigma-Aldrich, United States) and 0.26 g swine pepsin (Sigma-Aldrich, United States). The pH was adjusted to 2.5 with 1 N HCl, filter sterilized and then added to the gastrointestinal basic juice. Aliquots of 0.1 ml of bacterial cells suspensions obtained after three subcultures in M17 broth for 24 h were transferred to 0.9 ml of artificial gastric juice. After 1 h of incubation at 37°C with agitation at 200 rpm, microbial viability was evaluated by the micro drop technique. The medium for simulated intestinal conditions contained (per liter) 3 g Ox-bile extract (Sigma-Aldrich, St. Louis, MI, United States), 1.95 g pancreatin (Sigma-Aldrich, St. Louis, MI, United States) and 0.1 g lysozyme (Sigma-Aldrich, St. Louis, MI, United States). The pH was adjusted to 8.0 with 1 N sodium bicarbonate and the medium was filter sterilized. After gastric juice incubation, 1 ml of intestinal solution was added, and the incubation was continued at 37°C with agitation for further 3 and 5 h. Microbial viability was evaluated at each time point by the micro drop technique. The experiment was repeated three times with three technical replicates each.

Production of Histamine and Tyramine
------------------------------------

A defined decarboxylase medium was used ([@B38]) with some modifications. Five grams of tryptone, 8 g beef extract, 4 g yeast extract, 0.5 g tween-80, 0.2 g MgSO~4~, 0.05 g MnSO~4~, 0.04 g FeSO~4~, 0.1 g CaCO~3~, and 0.06 g bromocresol purple were dissolved in 1 l of deionized water and autoclaved at 121°C for 10 min. The pH of the medium was adjusted to 5.3 aseptically. Strains were grown in M17 broth overnight, washed three times with PBS and transferred to tubes containing the decarboxylase medium. After incubation at 30°C for 5 days, 200 μl of each culture were transferred to sterile tubes containing 2 ml of defined decarboxylase medium containing the specific amino acid [L]{.smallcaps}-histidine or [L]{.smallcaps}-tyrosine at 0.5% final concentration. All tubes were incubated for further 3 days at 30°C. The conversion of the color from yellow to purple was considered as positive response. The medium without amino acid addition was used as negative control. The experiment was performed with three technical replicates.

Furthermore, the eight *S. thermophilus* genomes ([@B65]) were inspected for the presence of genes involved in histamine and tyramine production by using BLASTn Megablast ([@B39]). For histamine, the histidine decarboxylation *hdc* cluster of *S. thermophilus* CHCC6483 (Accession number [FN686790.1](FN686790.1)) was used, while for tyramine the *tdcA* gene of *S. thermophilus* 1TT45 (accession number [FR682467](FR682467)) and *Lb. curvatus* HSCC1737 (Accession number [AB086652](AB086652)) were chosen.

Bile Salts Hydrolysis Activity
------------------------------

Fresh bacterial cultures were streaked onto M17 plates containing 0.5% taurodeoxycholic acid (Sigma-Aldrich, St. Louis, MI, United States). The hydrolytic activity was determined after 48 h of incubation at 37°C by inspecting the presence of a deoxycholic acid precipitation halo around positive colonies and into the surrounding medium. M17 plates without taurodeoxycholic acid were used as negative controls, whereas *Leuconostoc mesenteroides* SJRP 55 was used as positive control ([@B27]).

Extracellular Folate Production
-------------------------------

Folate production was quantified by using Folic Acid Casei medium (HIMEDIA laboratories, Mumbai, India) and *Lb.* *rhamnosus* ATCC 7469 as indicator strain ([@B24]). Increasing amounts of folic acid determine a proportional increase in the growth of *Lb.* *rhamnosus* ATCC 7469. The indicator strain was prepared in advance by growing the strain in AOAC medium (Difco, United States) at 37°C for 24 h. After incubation, cultures were centrifuged, and the pellet washed twice with 10 ml of sterile 0.85% NaCl. Finally, cells were resuspended in 10 ml of 0.85% NaCl and diluted 1:100. Fifty-microliters aliquots were used to inoculate the assay tubes, prepared as follows.

The strains to be tested were grown in a chemically defined medium ([@B43]) without folic acid at 37°C for 6, 18, and 24 h. After centrifugation, 1 ml of the supernatant was added to a tube containing 5 ml of Folic Acid Casei medium and 4 ml of deionized water to give a final volume of 10 ml. Tubes were autoclaved at 121°C for 5 min, then cooled down at room temperature. Each tube was inoculated with 50 μl of *Lb.* *rhamnosus* ATCC 7469 suspension, prepared as described above. After incubation at 37°C for 24 h, the optical density was measured at 620 nm and the results interpreted according to the standard curve by considering the dilution factor of the supernatants. The standard curve was obtained according to the manufacturer's instruction using 0.0, 0.1, 0.2, 0.4, 0.6, 0.8, and 1 ng of folic acid (Sigma-Aldrich, St. Louis, MI, United States) per assay tube (10 ml). The experiment was repeated twice with three technical replicates each.

Adhesion to HT-29 Cells
-----------------------

Bacterial adhesion to HT-29 cancer cells was tested as previously described ([@B26]), with the following modifications. HT-29 cells were grown in DMEM medium (Gibco BRL, United States) supplemented with 10% of heat-inactivated fetal bovine serum (Gibco BRL, United States) and 1% penicillin/streptomycin mixture (Gibco BRL, United States). Aliquots of 3 ml containing 1.5 × 10^5^ cells/ml were seeded on six-well Corning tissue culture plates and incubated at 37°C in 5% CO~2~ humid atmosphere until a complete monolayer was produced. The medium was changed every 48 h until a complete monolayer was formed. Then the medium was removed from the wells, plates were washed twice with sterile phosphate-buffered saline and filled with fresh antibiotic-free DMEM medium. Then plates were incubated at 37°C in 5% CO~2~ atmosphere for 30 min before adding the bacterial cells. The adherence test was performed by inoculating 120 μl of bacterial culture, suspended in antibiotic-free DMEM medium, at a concentration of about 1 × 10^8^ cfu/ml and incubating at 37°C for 3 h in 5% (v/v) CO~2~ atmosphere. After incubation, plates were washed four times with phosphate-buffered saline to release unbound bacteria. Fixation was carried out by adding 3 ml of methanol and incubating at room temperature for 10 min. Methanol was then removed and 3 ml of Giemsa stain solution (1:20) (Merck, Darmstadt, Germany) were added to the wells and again incubated at room temperature for 30 min to stain the cells. After staining, the wells were washed until no color was visible in the washing solution. Then plates were dried at 37°C and examined under an optical microscope at 1000× magnification. The adherent bacteria were counted in 20 random microscopic fields for each test. Bacterial strains were scored as non-adhesive when less than 40 bacteria were present in 20 fields, adhesive when containing 41--100 bacteria in 20 fields, and strongly adhesive when more than 100 bacteria were counted in 20 fields. The experiment was repeated three times with three technical replicates each.

Cytotoxic Activity Against HT-29 Cells
--------------------------------------

The cytotoxic activity of *S. thermophilus* stains against HT-29 colorectal cancer cells was evaluated through the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] tetrazolium reduction assay ([@B40]) with minor modifications. Aliquots of 100 μl of HT-29 cell in DMEM medium containing 1.2 × 10^5^ cells/ml were introduced in the wells of 96-wells microplates. After 24 h of incubation, the supernatants were collected, adjusted to pH 7.0 with 1 N NaOH, lyophilized, and serially diluted in DMEM at the following concentrations: 125, 250, 500, 750, 1000, 2000, 4000, and 8000 μg/ml. When 50% confluence was reached, the medium was replaced with 100 μl of filtered supernatant from *S.* *thermophilus* cultures at different concentrations and cells were incubated at 37°C for 48 h under 5% CO~2~ atmosphere. After incubation, 20 μl of PBS containing 5 mg/ml MTT were added to each well and further incubated for 4 h. Successively, 100 μl of DMSO (Sigma-Aldrich, United States) were added to each well to dissolve formazan crystals by 20 min stirring at 200 rpm. MTT reduction absorbance was measured at 570 nm using a microplate reader (SpectraMax M5, Molecular Devices, United States). In addition, cells were incubated with M17 alone and with 3% DMSO that were used as negative and positive controls, respectively. This test was performed only on the best three strains on the basis of previous tests. The experiment was repeated two times with three technical replicates each.

Statistical Analysis
--------------------

Data were analyzed by one-way analysis of variance (ANOVA) and Tukey's test was used as *post hoc* analysis. The IC~50~ (half maximal inhibitory concentration), which represents the dose necessary to inhibit half of the cells, was calculated by non-linear regression using the GraphPad Prism software (version 7, GraphPad Software, Inc., San Diego, CA, United States).

Results and Discussion
======================

Strains Characteristics
-----------------------

In this study, eight strains of *S*. *thermophilus* newly isolated from dairy environments in Italy (**Table [1](#T1){ref-type="table"}**) were studied to evaluate their potential probiotic properties. The genomes of these stains were previously sequenced and some genetic and metabolic characteristics had already been studied ([@B65]). In particular, all strains but 1F8CT were able to reach pH 5.2 within 24 h ([@B65]), and all grew at their best at 37°C, while TH1477 was the fastest at 42°C, and TH1436 at 34 and 30°C ([@B57]). Regarding the influence of the initial pH of the growth substrate, all strains grew very well at 7.0 while in a medium at pH 6.0 some strains (1F8CT and TH985) were significantly affected and at pH 5.5 all strains grew much slower, although with different kinetics ([@B56]). Regarding the use of different energy sources ([@B58]), all strains were obviously able to use lactose, but only M17PTZA496, MTH17CL396, and TH1436 could use galactose. It has to be considered that galactose accumulation in foods can lead to some unfavorable events, such as cheese fractures due to CO~2~ overproduction by heterofermentative bacteria, browning on heat-treated foods such as Mozzarella in pizza preparation, and toxic effects on persons affected by galactosemia, a genetic disease involving galactose metabolism ([@B67]). Strain TH1435 was the only one unable to use glucose, while only 1F8CT, MTH17CL396, and TH1435 were able to use fructose. None of the strains were able to use xylose, the constituent of xylooligosaccharides (XOS) and inulin, that can be considered a positive feature since these prebiotic molecules, that can be added to the fermented food, may arrive intact to the intestine where are used by the gut microbiota. Finally, strains M17PTZA496, MTH17CL396, and TH982 resulted good potential EPS produces, a positive technological property for fermented dairy products ([@B65]).

Hemolytic Activity Test
-----------------------

The lack of hemolytic activity is clearly one of the most important safety aspects to be considered for a food grade strain. Indeed, *in vitro* assessment of hemolytic activity on blood agar medium even for bacterial species that are considered GRAS is strongly recommended ([@B29]). None of the *S. thermophilus* strains under study showed β-hemolytic activity. All the strains were γ-hemolytic (i.e., without hemolytic activity) whereas *S. aureus* ATCC 6538, used as positive control, clearly showed β-hemolytic activity.

Antibiotic Susceptibility Test
------------------------------

Investigation of antibiotic susceptibility is another important safety aspect regarding bacteria intended to be used in foods. Although the species *S. thermophilus* possesses the GRAS status, the presence of antibiotic resistance must be checked at strain level, since genes could have been acquired by horizontal gene transfer. It is therefore specifically required that they do not carry any transferrable antibiotic resistance genes that can be passed to pathogenic bacteria ([@B13]). Contrary, intrinsic antibiotic resistance could be considered beneficial for the human host, to keep his gut microbiota alive during an antibiotic treatment ([@B10]). Antimicrobial susceptibility data are reported in **Table [2](#T2){ref-type="table"}**. All strains were susceptible to amoxicillin, ampicillin, cephalexin, chloramphenicol, erythromycin, penicillin G, tetracycline, and vancomycin, while all of them were resistant to streptomycin, kanamycin, and trimethoprim. According to previous studies ([@B2]) and the guidelines by [@B17], *S. thermophilus* strains are normally resistant to aminoglycosides antibiotics such as kanamycin, streptomycin, gentamicin, and trimethoprim. Therefore, this resistance is generally referred to as intrinsic and not able to be transferred horizontally. Regarding ciprofloxacin and cloxacillin, the strains showed different behavior: all were susceptible to ciprofloxacin and cloxacillin except TH1435 for ciprofloxacin and TH1435 and TH985 for cloxacillin, respectively, which evidenced intermediate resistance. These results indicate that the resistances found can be considered natural (intrinsic) and therefore not dangerous for human use, as confirmed by the presence of resistance to 6 out of 14 drugs tested that we found in the commercial strain *Lb. rhamnosus* GG (**Table [2](#T2){ref-type="table"}**), in accordance to what was also reported in a previous study ([@B11]).

###### 

Antibiotic susceptibility of S. *thermophilus* strains measured as diameters (mm) of inhibition haloes.

  Antibiotic        Amount (μg)   Strain                                                                        
  ----------------- ------------- -------- -------- -------- -------- ----------- ----------- -------- -------- -----------
  Amoxicillin       10            **32**   **32**   **33**   **32**   **28**      **28**      **29**   **34**   **21**
  Ampicillin        10            **35**   **30**   **35**   **34**   **27**      **29**      **28**   **34**   **19**
  Cephalexin        30            **31**   **30**   **32**   **31**   **32**      **29**      **26**   **33**   *12*
  Chloramphenicol   30            **33**   **27**   **33**   **32**   ***28***    **25**      **26**   **31**   **26**
  Ciprofloxacin     5             **32**   **26**   **33**   **27**   **21**      [18]{.ul}   **20**   **25**   [15]{.ul}
  Cloxacillin       5             **31**   **24**   **30**   **33**   [17]{.ul}   [17]{.ul}   **21**   **25**   [17]{.ul}
  Erythromycin      15            **25**   **28**   **33**   **32**   **29**      **28**      **24**   **33**   **21**
  Gentamicin        10            *12*     **16**   **18**   **17**   **17**      **15**      *11*     **27**   *0*
  Kanamycin         30            *11*     *6*      *12*     *14*     *12*        *10*        *6*      *11*     *0*
  Penicillin G      10 IU         **34**   **35**   **33**   **36**   **34**      **30**      **31**   **33**   **27**
  Streptomycin      10            *6*      *6*      *11*     *10*     *10*        *10*        *6*      *10*     *0*
  Tetracycline      30            **30**   **27**   **22**   **33**   **28**      **27**      **26**   **32**   **22**
  Trimethoprim      5             *6*      *6*      *6*      *6*      *6*         *6*         *6*      *6*      *0*
  Vancomycin        30            **27**   **23**   **24**   **23**   **20**      **20**      **20**   **25**   *0*
                                                                                                                

Susceptibility is indicated in bold, moderate susceptibility is underlined, and resistance is italicized. Cutoff values are taken from

Charteris et al. (1998)

.

Production of Biogenic Amines
-----------------------------

Biogenic amines produced by bacterial decarboxylation of amino acids can be found in many foods, particularly in fermented ones such as cheeses, wines, and beer ([@B22]). Although low levels of biogenic amines can be tolerated by humans, the ingestion of high amounts of these molecules, particularly histamine and tyramine, can cause food intoxication ([@B52]). For this reason, their production by a food-grade or probiotic strains should be low or absent. Regarding the strains studied in this work, the qualitative analysis performed on histamine and tyramine showed that only MTH17CL396 was able to produce both amines, while TH1436 produced tyramine only. The remaining six strains did not produce either of these two substances (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**) or could produce very low amounts that, according to ([@B6]) are not be able to induce the color change to purple. From the limited number of studies on the production of biogenic amines by *S. thermophilus* ([@B20]; [@B33]) it can be deduced that this characteristic is strongly strain dependent but, at least among the strains studied in this work, it appears to be a rare event.

We also performed an *in silico* analysis to look for genes related to biogenic amines production in the genomes of our strains. Results revealed that seven out of eight strains possess the histidine decarboxylation cluster *hdc* (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**) however, histamine production was detected only in *S. thermophilus* MTH17CL396. This outcome is in accordance with [@B20], which observed a weak correlation between histamine production and presence of the *hdc* gene. Anyway, it must be remarked that histamine production in *S. thermophilus* can be influenced by environmental conditions, as demonstrated by [@B49] that found *hdc*A expression upregulated under specific conditions, such as 2% NaCl. They also reported production of histamine in the presence of broken bacterial cells or cell extracts containing *hdcA*, since the enzyme, if produced, could be released in the medium. In order to adequately examine such occurrences, a specific study would be needed. Concerning tyrosine, *tdcA* was not detected in any of the *S. thermophilus* strains used in this work. Notwithstanding, *S. thermophilus* MTH17CL396 and TH1436 were able to decarboxylate tyrosine *in vitro* (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**), indicating that other gene(s) could be involved in this pathway, as hypothesized for *hdcA* ([@B20]).

Resistance to Simulated Gastrointestinal Conditions
---------------------------------------------------

Survival during passage through the gastrointestinal tract is the key factor for probiotics to be able to benefit the host ([@B4]). Recent studies reported conflicting data regarding the probiotic potential of *S. thermophilus*. Some authors are still discussing the viability of *S. thermophilus* after passage through the gastrointestinal tract. Indeed, it is well known that probiotic characteristics are strictly strain specific and this gives a strong motivation to keep seeking better strains ([@B53]). In our study, the resistance to simulated gastrointestinal conditions was investigated by incubating the cells for 1 h in gastric juice followed by 3 and 5 h in intestinal juice. The reference strain *Lb. rhamnosus* GG did not show any significant reduction in viability (**Figure [1](#F1){ref-type="fig"}**), but also *S. thermophilus* strains evidenced good resistance to gastric juice since reduction in viability was less than 1 log for most strains. Regarding the incubation in intestinal juice, following gastric passage, after 3 h strains MTH17CL396, M17PTZA496, TH985, and TH982 showed very good resistance while strain TH1436 had the lowest viability. Regarding the prolonged 5-h incubation, strains MTH17CL396, M17PTZA496, and TH982 confirmed very good viability levels, while TH985 had a dramatic decrease. In comparison with the commercial *Lb. rhamnosus* GG, most *S. thermophilus* strains showed just a slightly lower resistance to the gastric incubation test (**Figure [1](#F1){ref-type="fig"}**, brown bars), but *Lb. rhamnosus* appeared much less resistant to the intestinal conditions (1.5-log decrease), especially during prolonged incubation (3.4-log decrease), with respect to the best *S. thermophilus* strains MTH17CL396 (1.2-log decrease), M17PTZA496 (1.0-log decrease) and TH982 (2.0-log decrease). According to our results, some *S. thermophilus* strains showed better performances in comparison with the commercial *Lb. rhamnosus* GG strain regarding resistance to prolonged simulated intestinal conditions, particularly in the case of MTH17CL396, M17PTZA496, and TH982. Some authors reported that they were not able to recover *S. thermophilus* from human feces ([@B44]) while, on the other hand, [@B9] were able to recover *S. thermophilus,* during 6 days in a row, from fecal samples from 10 healthy subjects who had taken a pharmaceutical preparation orally for 3 days. Another study ([@B37]) strongly confirmed a significant recovery of viable *S. thermophilus* in human feces after yogurt consumption.

![Survival of *S. thermophilus* strains and *Lb. rhamnosus* GG during exposure to *in vitro* simulated gastrointestinal conditions. Results are expressed as the mean ± SD (*n* = 3). Upper-case letters indicate significant differences among treatments and lower-case letters indicate significant differences among the strains (*P* \< 0.05).](fmicb-09-02214-g001){#F1}

Bile Salts Hydrolytic Activity
------------------------------

None of the tested *S. thermophilus* strains revealed bile salt hydrolytic (BSH) activity when grown on M17 agar containing 0.5% taurodeoxycholic acid. BSH activity of probiotic bacteria has been a controversial debate during the last decades. Although BSH is somehow related to intestinal survival of probiotics and cholesterol lowering in the human host, however, it cannot be considered as a desirable property for probiotics, since de-conjugated bile salts could have many undesirable effects for the human host ([@B3]; [@B35]).

Extracellular Folate Production
-------------------------------

The capability to produce folate is of great interest for a potential probiotic strain, since it has been reported that consume of folate-producing bacteria can increase plasma folate concentration in humans ([@B64]). Folate is an important factor in the human diet, being involved in essential functions of cell metabolism such as DNA replication, repair, and methylation and synthesis of nucleotides. Several studies reported that folate deficiency is quite widespread among people, particularly in women ([@B31]). The recommended daily intake in adult has been reported differently from place to place ranging from 200 μg in Europe to 400 μg in the United States ([@B54]). Recently, some authors claimed that high-folate diets protect against cardiovascular diseases ([@B5]) and even against some forms of cancer ([@B1]). However, different LAB species and strains can have very different capabilities in folate production. While lactobacilli generally do not produce folate with the exception of *Lb. plantarum*, *L. lactis*, and *S. thermophilus* are considered good sources for production of folic acid ([@B12]; [@B54]). Extracellular folate concentration was monitored after 6, 18, and 24 h of bacterial growth to describe the trend of its production in the studied strains. Analysis on growth media revealed that all strains increased the amount of folate during growth (**Figure [2](#F2){ref-type="fig"}**). It should be noted that the highest amount of folate was measured after 18 h, which represents the late exponential phase. After that point, no significant differences were detected, and folate content remained constant. Extracellular folate production ranged from 5.06 to 147.67 ng/ml. Strains M17PTZA496 and TH982 showed the highest values, i.e., 147.67 and 95 ng/ml, respectively that was higher than that reported in literature ([@B54]).

![Kinetics of folate production detected in the medium during the growth of *S. thermophilus* strains. Error bars represent the standard deviation of each mean.](fmicb-09-02214-g002){#F2}

Adhesion to HT-29 Cancer Cells
------------------------------

The capability of bacteria to attach to the intestinal cells is another important key factor for probiotic microorganisms ([@B46]). Images of *S. thermophilus* strains attachment to HT-29 colorectal cancer cells are shown in **Figure [3](#F3){ref-type="fig"}** and data on adherence are reported in **Table [3](#T3){ref-type="table"}**. Strains MTH17CL396, M17PTZA496, TH982, TH985, TH1435, and TH1436 were strongly adhesive while the remaining showed a non-adhesive character. Moreover, strains MTH17CL396, M17PTZA496, TH982, and TH985 showed no significant difference (*P* \< 0.05) in adhesion score with respect to *Lb. rhamnosus* GG while *S. thermophilus* TH1435 and TH1436 showed a significantly (*P* \< 0.05) higher adhesive ability with respect to the reference strain. Adhesion ability of *S. thermophilus* strains was reported in several studies ([@B30]; [@B59]). High cell surface hydrophobicity and production of extracellular polysaccharides were the main reasons for this characteristic in bacteria ([@B50]; [@B55]). In this respect, a previous study ([@B65]) reported that strains MTH17CL396, M17PTZA496, and TH982 are good producers of exopolysaccharides. On the other hand, many authors reported that survival in the feces following oral administration may be directly linked to colonization of the intestine by attaching to the epithelium ([@B34]; [@B9]; [@B51]). Another study ([@B59]) revealed that the presence of lactose enhanced the fermentative activity of *S. thermophilus* leading to higher level of luminal lactate which subsequently acts to modulate the host epithelium. Therefore, activation of enzymes involved in carbohydrate metabolism constitutes the metabolic signature of *S. thermophilus* in the GIT and favors the interaction with the colon epithelium.

![Adhesion of *S. thermophilus* cells on HT-29 cell cultures observed under light microscope (100×). **Strains: (A)** *S. thermophilus* MTH17CL396, **(B)** *S. thermophilus* M17PTZA496, **(C)** *S. thermophilus* TH982, **(D)** *S. thermophilus* TH985, **(E)** *S. thermophilus* TH1435, **(F)** *S. thermophilus* TH1436, **(G)** Blank HT-29 cell line, **(H)** *Lb. rhamnosus* GG.](fmicb-09-02214-g003){#F3}

###### 

Adhesion potential of bacterial strains.

  Strain                         Adhesion score       Category
  ------------------------------ -------------------- -------------------
  *S. thermophilus* 1F8CT            14.8 ± 2.3^c^    Non-adhesive
  *S. thermophilus* MTH17CL396     383.9 ± 8.0^b^     Strongly adhesive
  *S. thermophilus* M17PTZA496     363. 3 ± 8.5^b^    Strongly adhesive
  *S. thermophilus* TH982          500.3 ± 6.0^b^     Strongly adhesive
  *S. thermophilus* TH985          456.1 ± 7.6^b^     Strongly adhesive
  *S. thermophilus* TH1435         506.1 ± 8.1^b^     Strongly adhesive
  *S. thermophilus* TH1436       1062.3 ± 9.1^a^      Strongly adhesive
  *S. thermophilus* TH1477            11.6 ± 1.9^c^   Non-adhesive
  *Lb. rhamnosus* GG                420.8 ± 8.1^b^    Strongly adhesive
                                                      

Scores are the average number of adhering cells in 20 microscopic fields ± SD (n = 3). Numbers with same letters do not differ significantly (P \< 0.05).

Cytotoxic Activity Against HT-29 Cell Line
------------------------------------------

The three strains that evidenced the most interesting characteristics during the tests described above and that have also technological potential according to previous studies ([@B65]), namely MTH17CL396, M17PTZA496, and TH982 were tested for cytotoxic activity against colorectal adenocarcinoma (HT-29) cells, using *Lb. rhamnosus* GG as reference strain. Results reveal that HT-29 cells were significantly inhibited by *S. thermophilus* MTH17CL396, M17PTZA496, and TH982 compared to the untreated cancer cell (**Table [4](#T4){ref-type="table"}**). For all concentrations, no significant difference (*P* \< 0.05) was found between *S. thermophilus* M17PTZ396 and *Lb. rhamnosus* GG when evaluated in a multiple comparison test (Tukey's test). This was also confirmed by the determination of the IC~50~ values against HT-29 cells that resulted 1.42 ± 0.12 mg/ml for *Lb. rhamnosus* GG and 0.9 ± 0.13 mg/ml for *S. thermophilus* M17PTZ396, not significantly different, while values from *S. thermophilus* M17PTZA496 and TH982 were lower in comparison to *Lb. rhamnosus* GG. Overall, after 48 h of incubation, all three *S. thermophilus* strains indicated good antiproliferative effect on HT-29 cancer cells (**Table [4](#T4){ref-type="table"}**). To exclude that such activity could be simply due to the lactic acid produced by all the bacteria tested, it is worth noticing that strain MTH17CL396, which displayed the best anticancer activity, has the worst acidification capability among the *S. thermophilus* strains tested, as previously reported ([@B65]). The inhibitory effect of *S. thermophilus* on HT-29 cells was previously demonstrated ([@B18]; [@B16]). Different mechanisms have been reported as to how LAB can inhibit colon cancer, which include enhancing the host's immune response, binding and degrading carcinogens, producing antimutagenic compounds, and altering the physiochemical conditions in the colon ([@B23]; [@B32]). Moreover, probiotic bacteria are able to decrease the level of some dangerous enzymes in the human body such as glycosidase, β-glucuronidase, azoreductase, and nitroreductase which convert the precarcinogens into active carcinogens ([@B21]; [@B44]).

###### 

Cytotoxic effect of different concentrations of lyophilized supernatant of *S. thermophilus* cultures, expressed as percentage of HT-29 cancer cells remained viable after 48 h of incubation.

  Supernatant concentration (μg/ml)   M17PTZA396    M17PTZA496    TH982         GG            M17 growth medium
  ----------------------------------- ------------- ------------- ------------- ------------- -------------------
  125                                 75.0 ± 0.02   93.7 ± 0.02   98.3 ± 0.01   65.8 ± 0.01   98.2 ± 0.05
  250                                 65.2 ± 0.04   78.0 ± 0.07   71.1 ± 0.03   63.9 ± 0.09   86.9 ± 0.06
  500                                 58.4 ± 0.12   65.3 ± 0.05   71.0 ± 0.05   58.9 ± 0.02   88.3 ± 0.11
  1000                                45.5 ± 0.07   62.5 ± 0.04   58.5 ± 0.01   54.1 ± 0.02   84.7 ± 0.06
  2000                                43.4 ± 0.05   61.8 ± 0.01   58.7 ± 0.05   48.2 ± 0.02   89.2 ± 0.05
  4000                                40.2 ± 0.03   58.8 ± 0.02   54.7 ± 0.04   41.1 ± 0.03   90.5 ± 0.05
  8000                                37.6 ± 0.03   57.6 ± 0.01   46.0 ± 0.04   29.1 ± 0.02   88.8 ± 0.24
                                                                                              

Lb. rhamnosus GG is the commercial reference probiotic strain. Growth medium M17 represents the negative control. A solution of 3% DMSO was used as positive control, which gave 26.2 ± 0.04 cell viability. Data are expressed as means ± SD.

Conclusion
==========

The results of this study revealed that two strains of *S. thermophilus,* namely M17PTZA496 and TH982 possess very interesting *in vitro* probiotic properties along with anticancer activity and folate production. These two newly isolated strains showed potential characteristics similar and, in some cases, superior to the well-known commercial probiotic strain *Lb. rhamnosus* GG. We believe that these two strains of *S. thermophilus* could be contemporarily used as good probiotics and starter strains, considering their technological properties. Although strain MTH17CL396 did not show relevant production of folic acid, and produces tyramine and histamine, it has shown a very high cytotoxic effect against cancer cells. Therefore, further assessment by *in vivo* studies to evaluate potential health benefits in humans is recommended for these strains. The presence of probiotic properties in *S. thermophilus* strains are of particular interest, since, differently from most probiotics on the market, this species has enormous relevance as technological starter used in large amounts for the production of cheeses and fermented milks. Overall, we could take a good advantage from this multipurpose species for both the food industry and human health.
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